Tms (4891) · RiskFirst stated

Uncertainty in Estimates of Potential Market Size and Patient Population

First written in FY2023. . Latest entry: FY2023.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Uncertainty Regarding Potential Pharmaceutical Market Size and Attainable Market ShareA theme 4 companies write about · 4 as a headwind · 0 as a tailwind

0 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Full recordFilings, disclosures and news, newest first

FY2023First statedAnnual report
「The Company estimates TAM (Total Addressable Market) based on estimates provided by third parties under specified assumptions and premises. Although it uses data it considers reliable, the accuracy of the estimates is subject to limitations.」
If third-party estimates or assumptions are inaccurate, the target patient population, drug prices and potential market size may be below expectations and the Company may fail to gain market share.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

No upcoming earnings preview for Tms yet.

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.